Stocksigma LogoStocksigma Logo

Godavari Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 2,823 (+5.9% YoY | +1.0% QoQ) ■ EBITDA: 280 (+40.1% YoY | +11.3% QoQ) ■ EBITDA Margin (%): 9.9 (+242 bps YoY | +92 bps QoQ) ■ PAT: 95.7 (-4.3%

Godavari Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Godavari Drugs Ltd · Outcome · 11 Nov 2026, 10:44 pm

Godavari Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 2,823 (+5.9% YoY | +1.0% QoQ) ■ EBITDA: 280 (+40.1% YoY | +11.3% QoQ) ■ EBITDA Margin (%): 9.9 (+242 bps YoY | +92 bps QoQ) ■ PAT: 95.7 (-4.3% YoY | -13.7% QoQ) ■ EPS (INR): 0.90 (-32.3% YoY | -18.2% QoQ)

Original exchange filing (PDF)

More announcements from Godavari Drugs Ltd

All Godavari Drugs Ltd announcements